Oxymetazoline: Difference between revisions
(Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug Ratings in...") |
|||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: | *Type: Decongestant; Adrenergic Agonist Agent; Imidazoline derivative | ||
*Dosage Forms: | *Dosage Forms: Solution; Nasal spray | ||
*Routes of Administration: | *Routes of Administration: Intranasal | ||
*Common Trade Names: | *Common Trade Names: 12-Hour Nasal Relieve Spray, Afrin, Mucinex | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 19:02, 12 August 2016
Administration
- Type: Decongestant; Adrenergic Agonist Agent; Imidazoline derivative
- Dosage Forms: Solution; Nasal spray
- Routes of Administration: Intranasal
- Common Trade Names: 12-Hour Nasal Relieve Spray, Afrin, Mucinex
Adult Dosing
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: